Market Tracker

07/03 4:45pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.30
Delayed Data
As of Jul 02
 +0.01 / +0.78%
Today’s Change
1.19
Today|||52-Week Range
1.89
-6.47%
Year-to-Date

Today’s Trading

Previous close1.29
Today’s open1.30
Day’s range1.29 - 1.31
Volume543,715
Average volume (3 months)1,104,177
Market cap$250.2M
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-36.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
NAVBNavidea Biopharmaceu...+0.06+3.70%
ZGNXZogenix Inc-1.16-8.31%
CORICorium International...-0.43-3.09%
PTXPernix Therapeutics ...-0.21-3.63%
Data as of 4:04pm ET, 07/02/2015

Financials

Next reporting dateJuly 13, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts